Quince Therapeutics, Inc. Common Stock
Symbol: QNCX (NASDAQ)
1.82
▼ (-11.03%) -0.225
Company Description:
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
Key Stats
- Today's Open: $2.1
- Today's High: $2.161
- Today's Low: $1.781
- Today's Volume: 491.37K
- Yesterday Close: $2.04
- Yesterday High: $2.1
- Yesterday Low: $1.841
- Yesterday Volume: 868.87K
- Last Min Volume: 5
- Last Min High: $1.815
- Last Min Low: $1.815
- Last Min VWAP: $1.815
Company Profile
- Name: Quince Therapeutics, Inc. Common Stock
- Website: https://www.quincetx.com
- Listed Date: 2019-05-09
- Location: SOUTH SAN FRANCISCO, CA
- Market Status: Active
- CIK Number: 0001662774
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $100.44M
- Round Lot: 100
- Outstanding Shares: 53.71M
- Asset Type: CS
RECENT FILINGS FOR QNCX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-26 | 8-K | View |
| 2025-08-14 | SCHEDULE 13G | View |
| 2025-08-11 | 10-Q | View |
| 2025-08-11 | 8-K | View |
| 2025-08-05 | EFFECT | View |
| 2025-08-05 | 424B5 | View |
| 2025-08-01 | CORRESP | View |
| 2025-08-01 | UPLOAD | View |
| 2025-07-25 | S-3 | View |
| 2025-07-16 | 8-K | View |
| 2025-07-01 | D | View |
| 2025-06-23 | 4 | View |
| 2025-06-23 | 4 | View |
| 2025-06-23 | 4 | View |
| 2025-06-13 | 8-K | View |
| 2025-06-06 | 4 | View |
| 2025-06-06 | 4 | View |
| 2025-06-06 | 4 | View |
| 2025-06-06 | 4 | View |
| 2025-06-06 | 4 | View |
Latest News on QNCX